The hormone glucose-dependent insulinotropic polypeptide (GIP) is considered obesogenic. In contrast, GIP receptor agonists (GIPRAs) have shown reduced feeding and body weight in an obese mouse model.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback